ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 208 | 216↑3.7% | 316↑46.4% | 487↑53.9% | 614↑26.2% |
| Gross Profit | 121 | 116↓4.8% | 178↑53.7% | 305↑71.9% | 364↑19.3% |
| Operating Income | -16 | -40↓148.5% | -35↑11.3% | 47↑233.1% | 1↓98.8% |
| Net Income | -23 | -43↓88.9% | -48↓12.4% | 19↑139.2% | -19↓198.6% |
| EBITDA | 28 | 3↓88.9% | 25↑703.6% | 107↑325.7% | 63↓40.8% |
| EPS Diluted | -1.88 | -3.40↓80.9% | -3.05↑10.3% | 0.94↑130.8% | -1.04↓210.6% |